Condition 1: Blood pressure. Condition 2: Heart rate.
Conditions
Interventions
Intervention 1: Intervention group one: In the dexmedetomidine 1 group, 1 (kg/µg) dexmedetomidine is infused within 10 minutes and then continued with a dose of 0.75 (kg/µg) dexmedetomidine infusion d
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with ASA (American Society of Anesthesiologists) = 1, aged 18-65 years, who are Patients aged 18-65 years Candidates for upper limb orthopedic surgery under tourniquet who undergo general anesthesia
Exclusion criteria
Exclusion criteria: Addicted people People with a history of allergy to the studied drugs People with heart, liver or kidney failure People with ASA = 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: At baseline times (before administration of study drugs) and then at times 0, 10, 20, 30, 40, 50 and 60 minutes after tourniquet inflation and then immediately after deflation. Method of measurement: Sphygmomanometer.;Heart rate. Timepoint: At baseline times (before administration of study drugs) and then at times 0, 10, 20, 30, 40, 50 and 60 minutes after tourniquet inflation and then immediately after deflation. Method of measurement: Electrocardiogram.;Oxygen saturation. Timepoint: At baseline times (before administration of study drugs) and then at times 0, 10, 20, 30, 40, 50 and 60 minutes after tourniquet inflation and then immediately after deflation. Method of measurement: Pulse oximeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzim Honarmand
Esfahan University of Medical Sciences
Outcome results
None listed